Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domenico Russo

Showing results (251-260 of 348) with videos related to

Pageof 35
Sort By:
Cancer Medicine|December 31, 2015
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patientsMichele Malagola, Cristina Skert, Erika Borlenghi, et al.
Blood|November 16, 2020
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88Antonio Sacco, Cinzia Federico, Arianna Giacomini, et al.
Frontiers in Oncology|July 5, 2022
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)Michele Malagola, Alessandro Turra, Liana Signorini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO GroupFrancesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Journal of Cellular and Molecular Medicine|October 22, 2025
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular VesiclesSilvia Mutti, Alessia Cavalleri, Stefania Federici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatmentIlaria Iacobucci, Gianantonio Rosti, Marilina Amabile, et al.
The EMBO Journal|May 13, 2017
Sphingolipid metabolic flow controls phosphoinositide turnover at the <i>trans</i>-Golgi networkSerena Capasso, Lucia Sticco, Riccardo Rizzo, et al.
Diseases (Basel, Switzerland)|June 2, 2021
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid LeukemiaCarmen Fava, Simona Bernardi, Enrico Marco Gottardi, et al.
Oncotarget|February 18, 2016
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patientsStefania Trino, Ilaria Iacobucci, Daniela Erriquez, et al.
Drug Design, Development and Therapy|July 21, 2021
A Call to Action by the Italian Mesotherapy Society on Scientific ResearchMassimo Mammucari, Teresa Paolucci, Domenico Russo, et al.
Pageof 35

Showing results (251-260 of 348) with videos related to

Sort By:
Pageof 35
Cancer Medicine|December 31, 2015
Postremission sequential monitoring of minimal residual disease by WT1 Q-PCR and multiparametric flow cytometry assessment predicts relapse and may help to address risk-adapted therapy in acute myeloid leukemia patientsMichele Malagola, Cristina Skert, Erika Borlenghi, et al.
Blood|November 16, 2020
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88Antonio Sacco, Cinzia Federico, Arianna Giacomini, et al.
Frontiers in Oncology|July 5, 2022
Results of an Innovative Program for Surveillance, Prophylaxis, and Treatment of Infectious Complications Following Allogeneic Stem Cell Transplantation in Hematological Malignancies (BATMO Protocol)Michele Malagola, Alessandro Turra, Liana Signorini, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2018
Busulfan- or Thiotepa-Based Conditioning in Myelofibrosis: A Phase II Multicenter Randomized Study from the GITMO GroupFrancesca Patriarca, Arianna Masciulli, Andrea Bacigalupo, et al.
Journal of Cellular and Molecular Medicine|October 22, 2025
Assessment of Chronic Myeloid Leukaemia In Vitro Models Variability: Insights Into Extracellular VesiclesSilvia Mutti, Alessia Cavalleri, Stefania Federici, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 20, 2006
Comparison between patients with Philadelphia-positive chronic phase chronic myeloid leukemia who obtained a complete cytogenetic response within 1 year of imatinib therapy and those who achieved such a response after 12 months of treatmentIlaria Iacobucci, Gianantonio Rosti, Marilina Amabile, et al.
The EMBO Journal|May 13, 2017
Sphingolipid metabolic flow controls phosphoinositide turnover at the <i>trans</i>-Golgi networkSerena Capasso, Lucia Sticco, Riccardo Rizzo, et al.
Diseases (Basel, Switzerland)|June 2, 2021
Alignment of Qx100/Qx200 Droplet Digital (Bio-Rad) and QuantStudio 3D (Thermofisher) Digital PCR for Quantification of BCR-ABL1 in Ph+ Chronic Myeloid LeukemiaCarmen Fava, Simona Bernardi, Enrico Marco Gottardi, et al.
Oncotarget|February 18, 2016
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: a new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patientsStefania Trino, Ilaria Iacobucci, Daniela Erriquez, et al.
Drug Design, Development and Therapy|July 21, 2021
A Call to Action by the Italian Mesotherapy Society on Scientific ResearchMassimo Mammucari, Teresa Paolucci, Domenico Russo, et al.
Pageof 35